Carisma Therapeutics, Inc.CARMNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank92
3Y CAGR+239.5%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+239.5%/yr
Annual compound
Percentile
P92
Near historical high
vs 3Y Ago
39.1x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 29.92% |
| 2023 | -57.99% |
| 2022 | -99.43% |
| 2021 | 0.76% |
| 2020 | 23.03% |
| 2019 | -43.47% |
| 2018 | -28.60% |
| 2017 | -424.12% |
| 2016 | 117.52% |
| 2015 | -6.88% |